205 related articles for article (PubMed ID: 18172498)
1. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
[TBL] [Abstract][Full Text] [Related]
2. Down's syndrome: paradox of a tumour repressor.
Threadgill DW
Nature; 2008 Jan; 451(7174):21-2. PubMed ID: 18172483
[No Abstract] [Full Text] [Related]
3. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
[TBL] [Abstract][Full Text] [Related]
4. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
[TBL] [Abstract][Full Text] [Related]
5. Increased survival following tumorigenesis in Ts65Dn mice that model Down syndrome.
Yang A; Reeves RH
Cancer Res; 2011 May; 71(10):3573-81. PubMed ID: 21467166
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in Down's syndrome: lessons from studies of human and mouse models.
Rueda N; Flórez J; Martínez-Cué C
Apoptosis; 2013 Feb; 18(2):121-34. PubMed ID: 23224708
[TBL] [Abstract][Full Text] [Related]
7. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of Down syndrome: gene content and consequences.
Gupta M; Dhanasekaran AR; Gardiner KJ
Mamm Genome; 2016 Dec; 27(11-12):538-555. PubMed ID: 27538963
[TBL] [Abstract][Full Text] [Related]
10. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models.
Galdzicki Z; Siarey RJ
Genes Brain Behav; 2003 Jun; 2(3):167-78. PubMed ID: 12931790
[TBL] [Abstract][Full Text] [Related]
11. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
12. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
Lyle R; Gehrig C; Neergaard-Henrichsen C; Deutsch S; Antonarakis SE
Genome Res; 2004 Jul; 14(7):1268-74. PubMed ID: 15231743
[TBL] [Abstract][Full Text] [Related]
13. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
14. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
[TBL] [Abstract][Full Text] [Related]
15. Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice.
Hill CA; Sussan TE; Reeves RH; Richtsmeier JT
Am J Med Genet A; 2009 Oct; 149A(10):2158-65. PubMed ID: 19764029
[TBL] [Abstract][Full Text] [Related]
16. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
17. Germ cell migration and early development of the gonads in the trisomy 16 mouse--an animal model for Down's syndrome.
Leffler A; Ludwig M; Schmitt O; Busch LC
Ann Anat; 1999 May; 181(3):247-52. PubMed ID: 10363106
[TBL] [Abstract][Full Text] [Related]
18. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Olson LE; Richtsmeier JT; Leszl J; Reeves RH
Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
[TBL] [Abstract][Full Text] [Related]
19. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
[TBL] [Abstract][Full Text] [Related]
20. Usp16 contributes to somatic stem-cell defects in Down's syndrome.
Adorno M; Sikandar S; Mitra SS; Kuo A; Nicolis Di Robilant B; Haro-Acosta V; Ouadah Y; Quarta M; Rodriguez J; Qian D; Reddy VM; Cheshier S; Garner CC; Clarke MF
Nature; 2013 Sep; 501(7467):380-4. PubMed ID: 24025767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
